$BAX Q3 '26 Earnings Results & Recap
• Reported GAAP EPS of $0.58 down -15.94% YoY
• Reported revenue of $2.98B up 4.97% YoY
• Baxter raised FY 2026 reported sales growth guidance to 4% to 5%, organic sales growth to 3% to 4%, and adjusted diluted EPS to $2.05 to $2.15.